Inhibition by vanadate of cyclic AMP production in rat corpora lutea incubated in vitro.

TitleInhibition by vanadate of cyclic AMP production in rat corpora lutea incubated in vitro.
Publication TypeJournal Article
Year of Publication1986
AuthorsLahav M, Rennert H, Barzilai D
JournalLife Sci
Volume39
Issue26
Pagination2557-64
Date Published1986 Dec 29
ISSN0024-3205
Keywords1-Methyl-3-isobutylxanthine, Animals, Calcium, Corpus Luteum, Cyclic AMP, Female, In Vitro Techniques, Luteinizing Hormone, Rats, Rats, Inbred Strains, Time Factors, Trifluoperazine, Vanadates, Vanadium
Abstract

Vanadate, a normal constituent of cells, has been reported to affect a variety of enzymes involved in phosphate transfer; the findings regarding adenylate cycle vary with the tissue and experimental system. In the corpus luteum, cyclic AMP (cAMP) stimulates steroidogenesis; and prostaglandin F2 alpha, which induces luteal regression, inhibits luteinizing hormone (LH)-induced cAMP accumulation. We examined the influence of orthovanadate on cAMP concentration in isolated corpora lutea from pseudopregnant rats. With 2 mM vanadate, basal cAMP level was unaffected, but LH-induced cAMP accumulation was inhibited by 45-68%. Lower doses of vanadate (0.2-1 mM) were almost as effective. When added simultaneously with LH, vanadate was inhibitory within 25 min, but no inhibition occurred when vanadate was added for 30 min to tissue pretreated with LH for 60 min. The decrease in cAMP accumulation was observed also when corpora lutea were exposed to vanadate in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (0.5 mM), indicating that vanadate inhibits cAMP synthesis. Vanadate may increase cytosolic calcium by inhibiting ion pumps in cell membranes. Thus, we examined the effect of vanadate in corpora lutea incubated in calcium-depleted medium and found that vanadate still inhibited cAMP formation. Vanadyl sulfate (0.4 and 2 mM) reduced the LH-induced cAMP accumulation as effectively as vanadate. Thus, the use of vanadate as a tool for exploring physiological regulators of luteal adenylate cyclase should be considered.

DOI10.1016/0024-3205(86)90109-8
Alternate JournalLife Sci
PubMed ID2432373
Related Faculty: 
Hanna Rennert, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700